Health Problems
FDA authorizes Novavax Covid-19 vaccine for emergency use in ages 12-17
In this age group, “overall, the clinical efficacy of the vaccine is around 80%,” said Silvia Taylor, Novavax’s senior vice president global corporate affairs. The vaccine has shown 90% overall efficacy in adults. Novavax announced in early July that its vaccine shows “broad” immune response to currently circulating variants, including Read more…
